HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Emery, V C Search for Related Content PubMed PubMed Citation Articles by Emery, V C Pubmed/NCBI databases Medline Plus Health Information Cytomegalovirus Infections

Investigation of CMV disease in immunocompromised patients

Department of Virology, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK

Professor Emery v.emery{at}rfc.ucl.ac.uk Cytomegalovirus (CMV) is a recognised cause of morbidity and mortality in immunocompromised individuals. This review will concentrate on recent advances in the understanding of the complex interplay between the host and parasite and the pathological consequences of perturbation of the host immune system. The classic view of CMV as a slowly replicating virus is challenged by recent in vivo findings suggesting that active replication occurs dynamically in the human host, with a doubling time of approximately one day. In addition, CMV load plays a major role in viral pathogenesis, such that increased CMV replication is a significant risk factor for disease in all immunocompromised groups studied to date. These studies focus attention on understanding the virological and immunological determinants of enhanced viral replication and its pathological consequences.

Key Words: polymerase chain reaction • quantitation • inclusion bodies • antiviral chemotherapy

This article has been cited by other articles:

				G. M. Scott, A. Weinberg, W. D. Rawlinson, and S. Chou Multidrug Resistance Conferred by Novel DNA Polymerase Mutations in Human Cytomegalovirus Isolates Antimicrob. Agents Chemother., January 1, 2007; 51(1): 89 - 94. [Abstract] [Full Text] [PDF]

				E. M. M. van Leeuwen, E. B. M. Remmerswaal, M. T. M. Vossen, A. T. Rowshani, P. M. E. Wertheim-van Dillen, R. A. W. van Lier, and I. J. M. ten Berge Emergence of a CD4+CD28- Granzyme B+, Cytomegalovirus-Specific T Cell Subset after Recovery of Primary Cytomegalovirus Infection J. Immunol., August 1, 2004; 173(3): 1834 - 1841. [Abstract] [Full Text] [PDF]

				A. Harari, S. Petitpierre, F. Vallelian, and G. Pantaleo Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy Blood, February 1, 2004; 103(3): 966 - 972. [Abstract] [Full Text] [PDF]

				P Kelleher and S A Misbah What is Good's syndrome? Immunological abnormalities in patients with thymoma J. Clin. Pathol., January 1, 2003; 56(1): 12 - 16. [Full Text] [PDF]